Market Overview:
The global SNP genotyping and analysis market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for personalized medicine, rising prevalence of genetic disorders, and technological advancements in SNP genotyping and analysis methods. The global SNP genotyping and analysis market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into dynamic allele-specific hybridization (DASH), molecular beacons (MBs), and SNP microarrays (SMAs). DASH held the largest share of the global SNP genotyping and analysis market in 2017 owing to its high accuracy rate as compared to other methods. On the basis of application, the market is segmented into pharmaceuticals & pharmacogenomics; diagnostic research; agricultural biotechnology; breeding & animal livestock. Pharmaceuticals & pharmacogenomics held a major share of this market in 2017 due to an increase in R&D spending by pharmaceutical companies for developing novel drugs that target specific genes or gene variants associated with various diseases.
Product Definition:
SNP genotyping and analysis is the process of identifying and studying genetic variations, or Single Nucleotide Polymorphisms (SNPs), in DNA. These variations can help researchers understand how different genes influence a person's health, development, and behavior. SNP genotyping and analysis is important for understanding the role that genetics plays in human health, as well as for developing new treatments for genetic disorders.
Dynamic Allele-Specific Hybridization:
SNP Genotyping and Analysis market is expected to grow at a lucrative rate during the forecast period due to increasing demand for personalized medicine. The technology helps in identifying variations between closely related DNA sequences, which are known as Single Nucleotide Polymorphisms (SNPs). SNP genotyping and analysis help in determining the biological variation among individuals, thus helping in disease diagnosis and treatment selection.
Molecular Beacons:
Molecular beacons are small molecules that can be used as a substitute for DNA in the detection of SNPs. They are more sensitive than TaqMan probes and easier to manufacture. The technology is still emerging, but it has been used effectively in several applications such as pharmacogenomics, biomarker discovery & development, and next-generation sequencing (NGS) genotyping & analysis markets.
Global SNP Genotyping.
Application Insights:
Pharmaceuticals and pharmacogenomics was the largest application segment in the market for SNP genotyping and analysis. This is owing to a rise in demand for personalized medicine, which involves determining genetic makeup of an individual to cater specific drugs or dosages. The advent of next-generation DNA sequencing has led to exponential increase in number of studies related to human genome, which includes identification and characterization of Single Nucleotide Polymorphism (SNP).
The agricultural biotechnology industry is expected to witness significant growth over the forecast period due largely on account of increased focus by companies operating within this sector on advanced technologies that enhance productivity while reducing costs associated with production processes such as plant breeding & livestock improvement.
Regional Analysis:
The European region dominated the global market in terms of revenue share in 2016. This can be attributed to the presence of a substantial number of research entities and universities engaged in genetic studies. Moreover, an increase in R&D investments by companies operating within this region is anticipated to fuel growth over the forecast period.
However, Asia Pacific is expected to grow at maximum rate during the forecast period due to rising government initiatives pertaining towards development of biotechnology industry coupled with increasing awareness about these services among end-users located within this region.
Growth Factors:
- Increasing demand for personalized medicine
- Growing number of research studies on human genetics and genomics
- Technological advancements in SNP genotyping and analysis tools
- Rising prevalence of genetic disorders and chronic diseases
- Growing awareness about the benefits of SNP genotyping and analysis
Scope Of The Report
Report Attributes
Report Details
Report Title
SNP Genotyping and Analysis Market Research Report
By Type
Dynamic Allele-Specific Hybridization, Molecular Beacons, SNP Microarrays
By Application
Pharmaceuticals and Pharmacogenomics, Diagnostic Research, Agricultural Biotechnology, Breeding and Animal Livestock
By Companies
Illumina, Roche, Life Technologies Corporation, Sequenom, Affymetrix, Fluidigm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global SNP Genotyping and Analysis Market Report Segments:
The global SNP Genotyping and Analysis market is segmented on the basis of:
Types
Dynamic Allele-Specific Hybridization, Molecular Beacons, SNP Microarrays
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceuticals and Pharmacogenomics, Diagnostic Research, Agricultural Biotechnology, Breeding and Animal Livestock
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina
- Roche
- Life Technologies Corporation
- Sequenom
- Affymetrix
- Fluidigm
Highlights of The SNP Genotyping and Analysis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dynamic Allele-Specific Hybridization
- Molecular Beacons
- SNP Microarrays
- By Application:
- Pharmaceuticals and Pharmacogenomics
- Diagnostic Research
- Agricultural Biotechnology
- Breeding and Animal Livestock
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the SNP Genotyping and Analysis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
SNP genotyping is a technique that uses DNA sequencing to identify variations in the sequence of a gene. This information can then be used to determine the genetic makeup of an individual. SNP analysis can be used to identify specific genetic variants that may influence health or susceptibility to disease.
Some of the major companies in the snp genotyping and analysis market are Illumina, Roche, Life Technologies Corporation, Sequenom, Affymetrix, Fluidigm.
The snp genotyping and analysis market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 SNP Genotyping and Analysis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 SNP Genotyping and Analysis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 SNP Genotyping and Analysis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the SNP Genotyping and Analysis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global SNP Genotyping and Analysis Market Size & Forecast, 2020-2028
4.5.1 SNP Genotyping and Analysis Market Size and Y-o-Y Growth
4.5.2 SNP Genotyping and Analysis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Dynamic Allele-Specific Hybridization
5.2.2 Molecular Beacons
5.2.3 SNP Microarrays
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceuticals and Pharmacogenomics
6.2.2 Diagnostic Research
6.2.3 Agricultural Biotechnology
6.2.4 Breeding and Animal Livestock
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global SNP Genotyping and Analysis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 SNP Genotyping and Analysis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Dynamic Allele-Specific Hybridization
9.6.2 Molecular Beacons
9.6.3 SNP Microarrays
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceuticals and Pharmacogenomics
9.10.2 Diagnostic Research
9.10.3 Agricultural Biotechnology
9.10.4 Breeding and Animal Livestock
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Dynamic Allele-Specific Hybridization
10.6.2 Molecular Beacons
10.6.3 SNP Microarrays
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceuticals and Pharmacogenomics
10.10.2 Diagnostic Research
10.10.3 Agricultural Biotechnology
10.10.4 Breeding and Animal Livestock
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Dynamic Allele-Specific Hybridization
11.6.2 Molecular Beacons
11.6.3 SNP Microarrays
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceuticals and Pharmacogenomics
11.10.2 Diagnostic Research
11.10.3 Agricultural Biotechnology
11.10.4 Breeding and Animal Livestock
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Dynamic Allele-Specific Hybridization
12.6.2 Molecular Beacons
12.6.3 SNP Microarrays
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceuticals and Pharmacogenomics
12.10.2 Diagnostic Research
12.10.3 Agricultural Biotechnology
12.10.4 Breeding and Animal Livestock
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Dynamic Allele-Specific Hybridization
13.6.2 Molecular Beacons
13.6.3 SNP Microarrays
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceuticals and Pharmacogenomics
13.10.2 Diagnostic Research
13.10.3 Agricultural Biotechnology
13.10.4 Breeding and Animal Livestock
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 SNP Genotyping and Analysis Market: Competitive Dashboard
14.2 Global SNP Genotyping and Analysis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Illumina
14.3.2 Roche
14.3.3 Life Technologies Corporation
14.3.4 Sequenom
14.3.5 Affymetrix
14.3.6 Fluidigm
